Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

Documenti analoghi

• Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
  di: Kline, Jeffrey A., et al.
  Pubblicazione: (2016)
• Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
  di: Prins, Martin H, et al.
  Pubblicazione: (2013)
• Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
  di: Boonyawat, Kochawan, et al.
  Pubblicazione: (2021)
• Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
  di: Martinelli, Ida, et al.
  Pubblicazione: (2016)
• Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
  di: Prins, Martin H, et al.
  Pubblicazione: (2013)